Brief: Cortexyme - Co Is Further Reducing Headcount By 36%, Bringing Total Reduction To 67% From January 2022 Headcount Levels

IRulya Therapeutics

02/05/2022 22:35

May 2 (Reuters) - Cortexyme Inc  CRTX.O :
    * CORTEXYME - CO IS FURTHER REDUCING HEADCOUNT BY 36%,
BRINGING
TOTAL REDUCTION TO 67% FROM JANUARY 2022 HEADCOUNT LEVELS
    * CORTEXYME - MAJORITY OF CURRENT REDUCTION IN FORCE IS
EXPECTED
TAKE PLACE BY END OF MAY 2022, & REMAINDER IS EXPECTED BE
COMPLETED BY END OF JULY 2022
    * CORTEXYME - IN CONNECTION WITH CURRENT REDUCTION IN FORCE,
CO
ESTIMATES THAT IT WILL INCUR EXPENSES OF ABOUT $0.7 MILLION

Source text: [ID: https://bit.ly/383cPqh]
Further company coverage:  CRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))